Schedule of computation of basic and diluted net earnings/(losses) per common share |
| | | | | | | | | | | | | | | Three months ended | | Nine months ended | | | September 30, | | September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | Basic numerator: | | | | | | | | | | | | | Net (loss) income attributable to common shareholders | | $ | (7,179) | | $ | 5,597 | | $ | (19,380) | | $ | 74 | Basic denominator: | | | | | | | | | | | | | Basic weighted average shares outstanding | | | 94,621,339 | | | 105,531,418 | | | 97,167,867 | | | 103,950,731 | Basic (loss) earnings per share | | $ | (0.08) | | $ | 0.05 | | $ | (0.20) | | $ | — | Diluted numerator: | | | | | | | | | | | | | (Loss) earnings attributable to common shareholders | | $ | (7,179) | | $ | 5,597 | | $ | (19,380) | | $ | 74 | Diluted denominator: | | | | | | | | | | | | | Diluted weighted average shares outstanding | | | 94,621,339 | | | 105,957,317 | | | 97,167,867 | | | 104,301,344 | Diluted (loss) earnings per share | | $ | (0.08) | | $ | 0.05 | | $ | (0.20) | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Net (loss) income per share data presented above excludes from the calculation of diluted net (loss) income, the following potentially dilutive securities, having an anti-dilutive impact, in case of net loss | | | | | | | | | | | | | Both vested and unvested options to purchase an equal number of shares of Common Stock | | | 4,713,363 | | | 2,606,771 | | | 4,713,363 | | | 2,631,246 | Unvested RSUs to issue an equal number of shares of Common Stock | | | 39,064 | | | 821,361 | | | 39,064 | | | 876,131 | Warrants to purchase an equal number of shares of Common Stock | | | 17,124,051 | | | 37,907,794 | | | 17,124,051 | | | 37,903,835 | Total number of potentially dilutive securities excluded from the calculation of earnings/(loss) per share attributable to common shareholders | | | 21,876,478 | | | 41,335,926 | | | 21,876,478 | | | 41,411,212 |
|